These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25236664)

  • 1. What happened to the modeling and simulation revolution?
    Bonate PL
    Clin Pharmacol Ther; 2014 Oct; 96(4):416-7. PubMed ID: 25236664
    [No Abstract]   [Full Text] [Related]  

  • 2. Impact of modeling and simulation: myth or fact?
    Allerheiligen SR
    Clin Pharmacol Ther; 2014 Oct; 96(4):413-5. PubMed ID: 25236663
    [No Abstract]   [Full Text] [Related]  

  • 3. The role of pharmacokinetic and pharmacokinetic/pharmacodynamic modeling in drug discovery and development.
    Yu XQ; Wilson AG
    Future Med Chem; 2010 Jun; 2(6):923-8. PubMed ID: 21426110
    [No Abstract]   [Full Text] [Related]  

  • 4. Metabolites: structure determination and prediction.
    Cruciani G
    Drug Discov Today Technol; 2013; 10(1):e145-6. PubMed ID: 24050243
    [No Abstract]   [Full Text] [Related]  

  • 5. Physiologically based pharmacokinetic (PBPK) modeling and simulation: applications in lead optimization.
    Peters SA; Ungell AL; Dolgos H
    Curr Opin Drug Discov Devel; 2009 Jul; 12(4):509-18. PubMed ID: 19562647
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22531680
    [No Abstract]   [Full Text] [Related]  

  • 7. Project ranks billions of drug interactions.
    Reardon S
    Nature; 2013 Nov; 503(7477):449-50. PubMed ID: 24284710
    [No Abstract]   [Full Text] [Related]  

  • 8. Connecting the dots: role of standardization and technology sharing in biological simulation.
    Ghosh S; Matsuoka Y; Kitano H
    Drug Discov Today; 2010 Dec; 15(23-24):1024-31. PubMed ID: 20934535
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Editorial. In silico ADMET predictions in pharmaceutical research.
    Hou T
    Adv Drug Deliv Rev; 2015 Jun; 86():1. PubMed ID: 26138539
    [No Abstract]   [Full Text] [Related]  

  • 10. Predicting Human Pharmacokinetics: Physiologically Based Pharmacokinetic Modeling and In Silico ADME Prediction in Early Drug Discovery.
    Shi J; Zha W
    Eur J Drug Metab Pharmacokinet; 2019 Feb; 44(1):135-137. PubMed ID: 30136219
    [No Abstract]   [Full Text] [Related]  

  • 11. Editorial: Theoretical Studies of the Metabolism in Drug Discovery.
    Scotti MT; Scotti L
    Curr Drug Metab; 2017; 18(6):498-499. PubMed ID: 28877659
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of discovery DMPK scientists in industry: where do we go from here?
    Moriwaki T
    Drug Metab Pharmacokinet; 2012; 27(2):169-70. PubMed ID: 22666880
    [No Abstract]   [Full Text] [Related]  

  • 13. Building predictive ADMET models for early decisions in drug discovery.
    Penzotti JE; Landrum GA; Putta S
    Curr Opin Drug Discov Devel; 2004 Jan; 7(1):49-61. PubMed ID: 14982148
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Physiologically based pharmacokinetics (PBPK).
    Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
    Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of physiologically based pharmacokinetic modeling and simulation in drug development.
    Shardlow CE; Generaux GT; Patel AH; Tai G; Tran T; Bloomer JC
    Drug Metab Dispos; 2013 Dec; 41(12):1994-2003. PubMed ID: 24009310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On nonoscillation and monotonicity of solutions of nonnegative and compartmental dynamical systems.
    Chellaboina V; Haddad WM; Bailey JM; Ramakrishnan J
    IEEE Trans Biomed Eng; 2004 Mar; 51(3):408-14. PubMed ID: 15000372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Better design of drug-eluting stents using computer modeling.
    Park K
    J Control Release; 2009 Jan; 133(1):1. PubMed ID: 19038297
    [No Abstract]   [Full Text] [Related]  

  • 18. An integrated, multidisciplinary approach for drug safety assessment.
    Li AP
    Drug Discov Today; 2004 Aug; 9(16):687-93. PubMed ID: 15341779
    [No Abstract]   [Full Text] [Related]  

  • 19. Model-based drug discovery: implementation and impact.
    Visser SA; Aurell M; Jones RD; Schuck VJ; Egnell AC; Peters SA; Brynne L; Yates JW; Jansson-Löfmark R; Tan B; Cooke M; Barry ST; Hughes A; Bredberg U
    Drug Discov Today; 2013 Aug; 18(15-16):764-75. PubMed ID: 23726890
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pfizer Sandwich Laboratories: where drug metabolism first met drug discovery.
    Smith D
    Xenobiotica; 2012 Jan; 42(1):2-3. PubMed ID: 22141758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.